Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125995161 | 12599516 | 1 | I | 20160429 | 20160721 | 20160727 | 20160727 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-48005BP | BOEHRINGER INGELHEIM | 63.55 | YR | F | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125995161 | 12599516 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 150 MG | 506918 | 22512 | 150 | MG | CAPSULE | QD | |||||
| 125995161 | 12599516 | 2 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | 0 | 10 | MG | QD | |||||||
| 125995161 | 12599516 | 3 | C | DIGOXIN. | DIGOXIN | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: GREATER THAN 125MCG | 0 | QD | |||||||||
| 125995161 | 12599516 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0.175 MCG | 0 | .175 | UG | QD | |||||||
| 125995161 | 12599516 | 5 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 20 MG | 0 | 20 | MG | QD | |||||||
| 125995161 | 12599516 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
| 125995161 | 12599516 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG | 0 | 75 | MG | QD | |||||||
| 125995161 | 12599516 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG | 0 | 50 | MG | QD | |||||||
| 125995161 | 12599516 | 9 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 240 MG | 0 | 240 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125995161 | 12599516 | 1 | Atrial fibrillation |
| 125995161 | 12599516 | 2 | Depression |
| 125995161 | 12599516 | 3 | Atrial fibrillation |
| 125995161 | 12599516 | 4 | Hypothyroidism |
| 125995161 | 12599516 | 5 | Blood cholesterol increased |
| 125995161 | 12599516 | 6 | Gastrooesophageal reflux disease |
| 125995161 | 12599516 | 7 | Hypertension |
| 125995161 | 12599516 | 8 | Hypertension |
| 125995161 | 12599516 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125995161 | 12599516 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125995161 | 12599516 | Asthenia | |
| 125995161 | 12599516 | Fatigue | |
| 125995161 | 12599516 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125995161 | 12599516 | 1 | 2014 | 0 |